Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
Pete Stibbs, Senior Vice President, Global Medical Affairs and Medical Director at Argon Medical Devices, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Vascular Surgery, adding:
“It is a pleasure to be at VIVA and The VEINS 2026 the Bellagio in Las Vegas and to have the opportunity to present our recently published 200-patient CleanerVac study in the Journal of Vascular Surgery: Venous and Lymphatic Disorders.
This multicenter study provides important real-world evidence on the use of the CleanerVac thrombectomy system across a broad and clinically representative patient population, adding to the growing body of evidence supporting mechanical thrombectomy in the management of venous thromboembolic disease.
A special thank you to Dr. Charbel Ishak and Dr. Paul Haser for sharing their clinical perspectives, experience, and individual case histories using the CleanerVac system.
The opportunity to combine published evidence with the practical experience of physicians treating these patients every day makes these discussions particularly valuable.
It is always rewarding to connect with colleagues and peers, exchange perspectives, and contribute to the evolving conversation around evidence-based venous and vascular care.”
Title: ARC-VAC Study (Analysis of Real-world multicenter experience with large bore Cleaner-VAC thrombectomy system), an analysis of 200 patients
Authors: Sameh Sayfo, Charbel Y. Ishak, Ilan Rzadkowolsky-Raoli, Mel M. Ghaleb, Peter Stibbs, Holly Harrison, Susan Powell, Jacqueline Finley

Other posts featuring Pete Stibbs on Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series